Literature DB >> 12928368

In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.

Víctor Gabriel Morón1, Paloma Rueda, Christine Sedlik, Claude Leclerc.   

Abstract

Recombinant parvovirus-like particles (PPV-VLPs) are particulate exogenous Ags that induce strong CTL response in the absence of adjuvant. In the present report to decipher the mechanisms responsible for CTL activation by such exogenous Ag, we analyzed ex vivo and in vitro the mechanisms of capture and processing of PPV-VLPs by dendritic cells (DCs). In vivo, PPV-VLPs are very efficiently captured by CD8alpha- and CD8alpha+ DCs and then localize in late endosomes of DCs. Macropinocytosis and lipid rafts participate in PPV-VLPs capture. Processing of PPV-VLPs does not depend upon recycling of MHC class I molecules, but requires vacuolar acidification as well as proteasome activity, TAP translocation, and neosynthesis of MHC class I molecules. This study therefore shows that in vivo DCs can cross-present PPV-VLPs using an endosome-to-cytosol processing pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928368     DOI: 10.4049/jimmunol.171.5.2242

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

Authors:  L Buonaguro; M L Tornesello; M Tagliamonte; R C Gallo; L X Wang; R Kamin-Lewis; S Abdelwahab; G K Lewis; F M Buonaguro
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Murine polyomavirus-like particles induce maturation of bone marrow-derived dendritic cells and proliferation of T cells.

Authors:  Thomas Bickert; Gisela Wohlleben; Marc Brinkman; Claudia M Trujillo-Vargas; Claus Ruehland; Christian O A Reiser; Juergen Hess; Klaus J Erb
Journal:  Med Microbiol Immunol       Date:  2006-08-18       Impact factor: 3.402

3.  Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells.

Authors:  Catherine Rybner-Barnier; Catherine Jacquemot; Céline Cuche; Grégory Doré; Laleh Majlessi; Marie-Madeleine Gabellec; Arnaud Moris; Olivier Schwartz; James Di Santo; Ana Cumano; Claude Leclerc; Françoise Lazarini
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 4.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

5.  CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.

Authors:  Young-Tae Lee; Eun-Ju Ko; Youri Lee; Yu-Na Lee; Zhen Bian; Yuan Liu; Sang-Moo Kang
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

6.  Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity.

Authors:  Olivier Renaudet; Gargi Dasgupta; Ilham Bettahi; Alda Shi; Anthony B Nesburn; Pascal Dumy; Lbachir BenMohamed
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

Review 7.  HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?

Authors:  Nuria Izquierdo-Useros; Mar Naranjo-Gómez; Itziar Erkizia; Maria Carmen Puertas; Francesc E Borràs; Julià Blanco; Javier Martinez-Picado
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

8.  Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.

Authors:  Julia Kim; Vandana Gambhir; Attiya Alatery; Sameh Basta
Journal:  J Biomed Biotechnol       Date:  2010-05-23

Review 9.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

10.  Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.

Authors:  Maria J Gonzalez; Emily M Plummer; Chris S Rae; Marianne Manchester
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.